{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:27:58Z","timestamp":1791282478730,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T00:00:00Z","timestamp":1190937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10585-007-9099-1","type":"journal-article","created":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T07:27:50Z","timestamp":1190878070000},"page":"33-42","source":"Crossref","is-referenced-by-count":34,"title":["A convenient clinically relevant model of human breast cancer bone metastasis"],"prefix":"10.1007","volume":"25","author":[{"given":"Teresa","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bachelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cl\u00e9ment-Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cl\u00e9zardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Pujuguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,28]]},"reference":[{"key":"9099_CR1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/cncr.11128","volume":"97","author":"JR Green","year":"2003","unstructured":"Green JR (2003) Antitumor effects of bisphosphonates. Cancer 97:840\u2013847","journal-title":"Cancer"},{"key":"9099_CR2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584\u2013593","journal-title":"Nat Rev Cancer"},{"key":"9099_CR3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537\u2013549","journal-title":"Cancer Cell"},{"key":"9099_CR4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Kang Y, Serganova I et al (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115:44\u201355","journal-title":"J Clin Invest"},{"key":"9099_CR5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1096\/fj.01-0911fje","volume":"16","author":"I P\u00e9cheur","year":"2002","unstructured":"P\u00e9cheur I, Peyruchaud O, Serre CM et al (2002) Integrin \u03b1v\u03b23 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J 16:1266\u20131268","journal-title":"FASEB J"},{"key":"9099_CR6","doi-asserted-by":"crossref","first-page":"45826","DOI":"10.1074\/jbc.M309024200","volume":"278","author":"O Peyruchaud","year":"2003","unstructured":"Peyruchaud O, Serre CM, NicAmhlaoibh R et al (2003) Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J Biol Chem 278:45826\u201345832","journal-title":"J Biol Chem"},{"key":"9099_CR7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/106652701753307502","volume":"8","author":"J Theilhaber","year":"2001","unstructured":"Theilhaber J, Bushnell S, Jackson A et al (2001) Bayesian estimation of fold-changes in the analysis of gene expression: the PFOLD algorithm. J Comput Biol 8:585\u2013614","journal-title":"J Comput Biol"},{"key":"9099_CR8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S8756-3282(03)00052-8","volume":"32","author":"S Roman-Roman","year":"2003","unstructured":"Roman-Roman S, Garcia T, Jackson A et al (2003) Identification of genes regulated during osteoblastic differentiation by genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone 32:474\u2013482","journal-title":"Bone"},{"key":"9099_CR9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/bdrc.20043","volume":"75","author":"TM Schroeder","year":"2005","unstructured":"Schroeder TM, Jensen ED, Westendorf JJ (2005) Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 75:213\u2013225","journal-title":"Birth Defects Res C Embryo Today"},{"key":"9099_CR10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrd2110","volume":"5","author":"NE Sharpless","year":"2006","unstructured":"Sharpless NE, DePinho RA (2006) The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5:741\u2013754","journal-title":"Nat Rev Drug Discov"},{"key":"9099_CR11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","volume":"12","author":"P Steeg","year":"2006","unstructured":"Steeg P (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895\u2013904","journal-title":"Nat Med"},{"key":"9099_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gde.2004.12.001","volume":"15","author":"SA Eccles","year":"2005","unstructured":"Eccles SA (2005) Targeting key steps in metastatic tumour progression. Curr Opin Genet Dev 15:77\u201386","journal-title":"Curr Opin Genet Dev"},{"key":"9099_CR13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cncr.11150","volume":"97","author":"TJ Rosol","year":"2003","unstructured":"Rosol TJ, Tannehill-Gregg SH, LeRoy BE et al (2003) Animal model of bone metastasis. Cancer 97:748\u2013757","journal-title":"Cancer"},{"key":"9099_CR14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0002-9440(10)64934-6","volume":"160","author":"A Wetterwald","year":"2002","unstructured":"Wetterwald A, van der Pluijm G, Que I et al (2002) Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 160:1143\u20131153","journal-title":"Am J Pathol"},{"key":"9099_CR15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrd1635","volume":"4","author":"A Kamb","year":"2005","unstructured":"Kamb A (2005) What\u2019s wrong with our cancer models. Nat Rev Drug Discov 4:161\u2013165","journal-title":"Nat Rev Drug Discov"},{"key":"9099_CR16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ccr.2005.05.019","volume":"7","author":"LE Littlepage","year":"2005","unstructured":"Littlepage LE, Egeblad M, Werb Z (2005) Coevolution of cancer and stromal cellular responses. Cancer cell 7:499\u2013500","journal-title":"Cancer cell"},{"key":"9099_CR17","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-04-1408","volume":"65","author":"C Kuperwasser","year":"2005","unstructured":"Kuperwasser C, Dessain S, Bierbaum BE et al (2005) A mouse model of human breast cancer metastasis to human bone. Cancer Res 65:6130\u20136138","journal-title":"Cancer Res"},{"key":"9099_CR18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van\u2019t Veer","year":"2002","unstructured":"van\u2019t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530\u2013536","journal-title":"Nature"},{"key":"9099_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1083\/jcb.150.1.177","volume":"150","author":"LY Bourguignon","year":"2000","unstructured":"Bourguignon LY, Zhu H, Shao L et al (2000) Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration. J Cell Biol 150:177\u2013191","journal-title":"J Cell Biol"},{"key":"9099_CR20","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0002-9440(10)61773-7","volume":"159","author":"G Pluijm van der","year":"2001","unstructured":"van der Pluijm G, Sijmons B, Vloedgraven H et al (2001) Urokinase-receptor\/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo. Am J Pathol 159:971\u2013982","journal-title":"Am J Pathol"},{"key":"9099_CR21","first-page":"55","volume":"148","author":"N Matsuura","year":"1996","unstructured":"Matsuura N, Puzon-McLaughlin W, Irie A et al (1996) Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. Am J Pathol 148:55\u201361","journal-title":"Am J Pathol"},{"key":"9099_CR22","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI119435","volume":"99","author":"T Yoneda","year":"1997","unstructured":"Yoneda T, Sasaki A, Dunstan C et al (1997) Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 99:2509\u20132517","journal-title":"J Clin Invest"},{"key":"9099_CR23","first-page":"679","volume":"328","author":"T Yoneda","year":"2005","unstructured":"Yoneda T, Hiraga T (2005) Crosstalk between cancer cells and bone microenvironment in bone metastasis. BBRC 328:679\u2013687","journal-title":"BBRC"},{"key":"9099_CR24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06534.x","volume":"905","author":"T Hla","year":"2000","unstructured":"Hla T, Lee MJ, Ancellin N et al (2000) Sphingosine-1-phosphate signaling via the EDG-1 family of G-protein-coupled receptors. Ann N Y Acad Sci 905:16\u201324","journal-title":"Ann N Y Acad Sci"},{"key":"9099_CR25","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","volume":"114","author":"A Boucharaba","year":"2004","unstructured":"Boucharaba A, Serre MC, Gres S et al (2004) Platelet-derived lysophosphatidic acid supports the progession of osteolytic bone metastases in breast cancer. J Clin Invest 114:1714\u20131725","journal-title":"J Clin Invest"},{"key":"9099_CR26","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","volume":"170","author":"A Li","year":"2003","unstructured":"Li A, Dubey S, Varney ML et al (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369\u20133376","journal-title":"J Immunol"},{"key":"9099_CR27","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","volume":"65","author":"MS Bendre","year":"2005","unstructured":"Bendre MS, Marguiles AG, Wasler B et al (2005) Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res 65:11001\u201311009","journal-title":"Cancer Res"},{"key":"9099_CR28","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1158\/0008-5472.CAN-04-3601","volume":"65","author":"SJ Kim","year":"2005","unstructured":"Kim SJ, Uehara H, Yazici S et al (2005) Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer. Cancer Res 65:3707\u20133715","journal-title":"Cancer Res"},{"key":"9099_CR29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","volume":"28","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 28:518\u2013524","journal-title":"Nature"},{"key":"9099_CR30","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/ng1434","volume":"36","author":"E Segal","year":"2004","unstructured":"Segal E, Friedman N, Koller D et al (2004) A module map showing conditional activity of expression modules in cancer. Nat Genet 36:1090\u20131098","journal-title":"Nat Genet"},{"key":"9099_CR31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","volume":"440","author":"DH Jones","year":"2006","unstructured":"Jones DH, Nakashima T, Sanchez OH et al (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440:692\u2013696","journal-title":"Nature"},{"key":"9099_CR32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/geno.1998.5707","volume":"56","author":"RW Berg","year":"1999","unstructured":"Berg RW, Leung E, Gough S et al (1999) Cloning and characterization of a novel beta integrin-related cDNA coding for the protein TIED (\u201cten beta integrin EGF-like repeat domains\u201d) that maps to chromosome band 13q33: A divergent stand-alone integrin stalk structure. Genomics 56:169\u2013178","journal-title":"Genomics"},{"key":"9099_CR33","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1083\/jcb.129.4.1127","volume":"129","author":"SN Gettner","year":"1995","unstructured":"Gettner SN, Kenyon C, Reichardt LF (1995) Characterization of beta pat-3 heterodimers, a family of essential integrin receptors in C. elegans. J Cell Biol 129:1127\u20131141","journal-title":"J Cell Biol"},{"key":"9099_CR34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673\u2013687","journal-title":"Cell"},{"key":"9099_CR35","first-page":"722","volume":"4","author":"GC Tucker","year":"2003","unstructured":"Tucker GC (2003) Alpha v integrin inhibitors and cancer therapy. Curr Opin Investig Drugs 4:722\u2013731","journal-title":"Curr Opin Investig Drugs"},{"key":"9099_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-006-9279-8","volume":"101","author":"A Bellahcene","year":"2006","unstructured":"Bellahcene A, Bachelier R, Detry C et al (2006) Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Res Treat 101:135\u2013148","journal-title":"Breast Cancer Res Treat"},{"key":"9099_CR37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/(SICI)1097-0045(19990601)39:4<246::AID-PROS5>3.0.CO;2-U","volume":"39","author":"KS Koeneman","year":"1999","unstructured":"Koeneman KS, Yeung F, Chung LW (1999) Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 39:246\u2013261","journal-title":"Prostate"},{"key":"9099_CR38","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/MCB.25.19.8581-8591.2005","volume":"25","author":"J Pratap","year":"2005","unstructured":"Pratap J, Javed A, Languino LR et al (2005) The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 25:8581\u20138591","journal-title":"Mol Cell Biol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-007-9099-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9099-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T14:32:52Z","timestamp":1559226772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-007-9099-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,28]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9099"],"URL":"https:\/\/doi.org\/10.1007\/s10585-007-9099-1","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,28]]}}}